Clinical & Pharma

Can Intranasal Stem Cells Heal Newborn Brain Damage?
Clinical & Pharma Can Intranasal Stem Cells Heal Newborn Brain Damage?

In a world where neonatal brain injuries can alter the course of a child’s life before it even truly begins, a groundbreaking development in medical science offers a glimmer of hope for families facing such challenges with the potential to transform pediatric care. Researchers at Wilhelmina

Coroner Warns of Fatal Flaws in Penicillin Allergy Checks
Clinical & Pharma Coroner Warns of Fatal Flaws in Penicillin Allergy Checks

In a deeply troubling incident that has reverberated through the medical field, Margaret McNaughton tragically passed away on December 13, 2024, at New Cross Hospital in Wolverhampton, UK, after suffering a fatal allergic reaction to a penicillin-based antibiotic. Despite her documented allergy to

Cuba Issues Health Alert Over Suspected XFG Variant Spread
Clinical & Pharma Cuba Issues Health Alert Over Suspected XFG Variant Spread

Amid growing concerns over a potential new wave of respiratory illnesses, Cuban health authorities have issued a critical alert across multiple provinces due to the suspected presence of the XFG variant, a highly transmissible subvariant of the Omicron strain of the coronavirus. This development

How Will Trump's Tariffs Impact Ireland's Pharma Industry?
Clinical & Pharma How Will Trump's Tariffs Impact Ireland's Pharma Industry?

President Donald Trump's recent announcement of potential tariffs on imported pharmaceuticals has sent shockwaves through global markets, with Ireland, a powerhouse in the pharmaceutical sector, standing at the forefront of concern. As a key supplier to the U.S. market, Ireland faces the daunting

Global Cancer Mortality Trends in Youth: Disparities Persist
Clinical & Pharma Global Cancer Mortality Trends in Youth: Disparities Persist

Cancer stands as a formidable challenge to the health of children, adolescents, and young adults across the globe, claiming countless lives each year with a burden that varies dramatically by region and circumstance. A comprehensive study analyzing data from 77 countries over a span of three

Takeda Pharmaceutical Stock: Mixed Signals and Outlook
Clinical & Pharma Takeda Pharmaceutical Stock: Mixed Signals and Outlook

In the ever-shifting landscape of the pharmaceutical industry, Takeda Pharmaceutical Co ADR (TAK) stands as a notable contender, drawing significant attention from investors navigating the complexities of the stock market. With a market capitalization of $44.28 billion and a workforce of over

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later